Summary
- Current Price
- As of today, AMLX price is $17.97, down -1.64% on
- Current Price All-Time High
- AMLX price is currently -57.14% below its historical high of $41.93 set on
- Market Cap
- AMLX current market cap is $2B, up +255.72% over the past 365 days
- PE Ratio
- AMLX PE ratio is unknown
- Revenue
- AMLX current annual revenue is $0.00, down -100.00% year-over-year
- Next Earnings
- The next earnings release for AMLX is on
Profile
| Metric | Value |
|---|---|
| Full Name | Amylyx Pharmaceuticals, Inc. |
| Ticker | NASDAQ: AMLX |
| Exchange | NASDAQ |
| Sector | Healthcare |
| Industry | Specialty & Generic Drug Manufacturers |
| Country | United States |
| IPO | |
| Indexes | Not included |
| Website | amylyx.com |
| Employees | 123 |
Key Metrics
| Metric | Date | Value |
|---|---|---|
| Price | $17.97 | |
| Price, 1D Change | -1.64% | |
| $2B | ||
| - | ||
| - | ||
| 1.20 | ||
| $0 | ||
| Revenue, 1Y Change | -100.00% | |
| -$1.53 | ||
| EPS, 1Y Change | +65.44% |
Chart
Events
| Metric | Date | Value |
|---|---|---|
| Next Earnings | ||
| Last Qtr. Earnings | ||
| Last Ann. Earnings | ||
| Last Ex-Dividend | N/A | N/A |
| Next Ex-Dividend | N/A | N/A |
| Last Split | N/A | N/A |
| Next Split | N/A | N/A |
| Last Ticker Change | N/A | N/A |
| Next Ticker Change | N/A | N/A |
🔒 Log In To Unlock Full Data
Estimates
| Metric | Date | Value |
|---|---|---|
| -$1.53 | ||
| EPS Estimate | N/A | -$1.38 |
| EPS Est. Change | N/A | +9.53% |
| $0.00 | ||
| Revenue Estimate | N/A | - |
| Revenue Est. Change | N/A | - |
| Current Price | $17.97 | |
| Price Target | - | $21.50 |
| Price Tgt. Change | - | +19.64% |
🔒 Log In To Unlock Full Data
EPS
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| -$4.30 | -$4.43 | -3.10% | |
| -$1.52 | -$1.53 | -0.96% | |
| -$1.38 | N/A | +9.53% | |
| -$1.27 | N/A | +17.28% |
Revenue
| Year | Estimate | Reported | Surprise / Exp. |
|---|---|---|---|
| $88.03M | $87.37M | -0.75% | |
| - | $0.00 | - | |
| - | N/A | - | |
| $40.50M | N/A | - |
🔒 Log In To Unlock Full Data
Performance
Technicals
| Metric | Date | Value |
|---|---|---|
| Current Price | $17.97 | |
| $14.39 | ||
| $15.23 | ||
| $13.68 | ||
| $15.60 | ||
| $1.02 | ||
| 1.20 | ||
| $1.00 | ||
| 66.57 | ||
| 43.89% | ||
| 61.70% |
Dividends
| Metric | Date | Value |
|---|---|---|
| N/A | - | |
| Upcoming | N/A | N/A |
| - | ||
| - | ||
| $0.00 | ||
| 0.00% |
🔒 Log In To Unlock Full Data
Income & Profitability
| Metric | Date | Value |
|---|---|---|
| $0.00 | ||
| -$1.53 | ||
| -$525.00K | ||
| - | ||
| -$153.29M | ||
| - | ||
| -$144.74M | ||
| - | ||
| -$152.77M |
🔒 Log In To Unlock Full Data
Financial Health
| Metric | Date | Value |
|---|---|---|
| 0.02 | ||
| 14.27 | ||
| 14.27 | ||
| - | ||
| - | ||
| 38.02 |
Valuations
| Metric | Date | Value |
|---|---|---|
| - | ||
| - | ||
| 7.31 | ||
| -10.86 | ||
| N/A | - |
Balance Sheet
| Metric | Date | Value |
|---|---|---|
| $305.26M | ||
| $316.98M | ||
| $334.07M | ||
| $323.67M | ||
| $28.82M | ||
| $22.69M | ||
| $5.96M | ||
| $1.26M | ||
| $3.52M |
Expenses
| Metric | Date | Value |
|---|---|---|
| $144.74M | ||
| $152.77M | ||
| $525.00K | ||
| $0.00 | ||
| $525.00K | ||
| $0.00 | ||
| $46.00K |
Cash Flow
| Metric | Date | Value |
|---|---|---|
| -$123.34M | ||
| $14.04M | ||
| $257.03M | ||
| $138.00K | ||
| -$123.48M |
Recent analyst updates
| Metric | Date | Value |
|---|---|---|
| Guggenheim | → | |
| Mizuho | → | |
| HC Wainwright & Co. | → | |
| Guggenheim | → | |
| HC Wainwright & Co. | → | |
| Stifel | ||
| B of A Securities | → | |
| HC Wainwright & Co. | → | |
| HC Wainwright & Co. | → | |
| Citigroup | → |
Analyst sentiment
Institutional ownership
Screeners with AMLX
FAQ
What is the ticker symbol for Amylyx Pharmaceuticals, Inc.?
The ticker symbol for Amylyx Pharmaceuticals, Inc. is NASDAQ:AMLX
Does Amylyx Pharmaceuticals, Inc. pay dividends?
No, Amylyx Pharmaceuticals, Inc. does not pay dividends
What sector is Amylyx Pharmaceuticals, Inc. in?
Amylyx Pharmaceuticals, Inc. is in the Healthcare sector
What industry is Amylyx Pharmaceuticals, Inc. in?
Amylyx Pharmaceuticals, Inc. is in the Specialty & Generic Drug Manufacturers industry
What country is Amylyx Pharmaceuticals, Inc. based in?
Amylyx Pharmaceuticals, Inc. is headquartered in United States
When did Amylyx Pharmaceuticals, Inc. go public?
Amylyx Pharmaceuticals, Inc. initial public offering (IPO) was on January 7, 2022
Is Amylyx Pharmaceuticals, Inc. in the S&P 500?
No, Amylyx Pharmaceuticals, Inc. is not included in the S&P 500 index
Is Amylyx Pharmaceuticals, Inc. in the NASDAQ 100?
No, Amylyx Pharmaceuticals, Inc. is not included in the NASDAQ 100 index
Is Amylyx Pharmaceuticals, Inc. in the Dow Jones?
No, Amylyx Pharmaceuticals, Inc. is not included in the Dow Jones index
When was Amylyx Pharmaceuticals, Inc. last earnings report?
Amylyx Pharmaceuticals, Inc.'s most recent earnings report was on May 7, 2026
When does Amylyx Pharmaceuticals, Inc. report earnings?
The next expected earnings date for Amylyx Pharmaceuticals, Inc. is August 6, 2026
Data Sources & References
- AMLX Official Website amylyx.com
- Most Recent Annual Report (10-K) www.sec.gov/Archives/edgar/data/1658551/000119312526086645/0001193125-26-086645-index.htm
- AMLX Profile on Yahoo Finance finance.yahoo.com/quote/AMLX
- AMLX Profile on NASDAQ.com www.nasdaq.com/market-activity/stocks/amlx